
Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and... Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, Rencofilstat, is being developed to offer benefits to address these multiple complex pathologies. Rencofilstat is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0126 | -6.73796791444 | 0.187 | 0.2252 | 0.1708 | 15317662 | 0.19713675 | CS |
4 | 0.0437 | 33.4353481255 | 0.1307 | 0.28 | 0.121 | 34844117 | 0.20108378 | CS |
12 | -0.5056 | -74.3529411765 | 0.68 | 0.7345 | 0.121 | 11907438 | 0.20261558 | CS |
26 | -0.4776 | -73.2515337423 | 0.652 | 0.89 | 0.121 | 5111723 | 0.20485111 | CS |
52 | -2.8756 | -94.2819672131 | 3.05 | 3.33 | 0.121 | 2596666 | 0.22276435 | CS |
156 | -20.4256 | -99.1533980583 | 20.6 | 26.6 | 0.121 | 1036267 | 2.55780003 | CS |
260 | -95.2256 | -99.8171907757 | 95.4 | 123.6 | 0.121 | 1373353 | 25.18933948 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.